- 5.2Impact Factor
- 10.5CiteScore
- 16 daysTime to First Decision
Special Issues
Cells publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Brain Organoids for Disease Modeling
Deadline: 30 September 2026
The Role of Stem Cells in Retinal Conditions
Deadline: 10 August 2026
Human Pluripotent Stem Cells and Organoids: Current Trends and Future Perspectives
Deadline: 1 June 2026
Immunoregulatory Functions of Mesenchymal Stem Cells (MSCs)
Deadline: 31 May 2026
Emerging Advances in Neurodegeneration: Innovations in Stem Cell and Organoid Research
Deadline: 31 May 2026
Stem Cells and Beyond: Innovations in Tissue Repair and Regeneration
Deadline: 31 May 2026
Stem Cell-Based Strategies for Cardiac Tissue Engineering and Regeneration
Deadline: 31 May 2026
Advances in Musculoskeletal Tissue Regeneration Using Mesenchymal Stromal/Stem Cells, Biomaterials, and Signaling Molecules: Second Edition
Deadline: 25 May 2026
Stem Cell Secretome: Therapeutic Potential in Regenerative Medicine
Deadline: 20 May 2026
Immune Cells from Pluripotent Stem Cells
Deadline: 30 April 2026
Post-Transcriptional Control of Stem Cell Fate and Neural Development
Deadline: 30 April 2026
Stem Cells in Action: Unlocking the Potential of Next-Generation Therapies
Deadline: 25 April 2026
of 9

